Free Trial

HSBC Reaffirms Hold Rating for UnitedHealth Group (NYSE:UNH)

UnitedHealth Group logo with Medical background

HSBC restated their hold rating on shares of UnitedHealth Group (NYSE:UNH - Free Report) in a research note published on Tuesday morning, Marketbeat.com reports. HSBC currently has a $490.00 price target on the healthcare conglomerate's stock.

Other analysts also recently issued research reports about the stock. Truist Financial lowered their target price on shares of UnitedHealth Group from $660.00 to $580.00 and set a "buy" rating on the stock in a report on Monday, April 21st. Wells Fargo & Company cut their target price on UnitedHealth Group from $694.00 to $660.00 and set an "overweight" rating for the company in a research note on Tuesday, January 28th. Mizuho boosted their price objective on shares of UnitedHealth Group from $600.00 to $650.00 and gave the stock an "outperform" rating in a report on Wednesday, April 9th. KeyCorp cut their target price on shares of UnitedHealth Group from $650.00 to $575.00 and set an "overweight" rating for the company in a research note on Monday, April 21st. Finally, Oppenheimer decreased their price objective on UnitedHealth Group from $640.00 to $600.00 and set an "outperform" rating on the stock in a report on Monday, April 21st. Three research analysts have rated the stock with a hold rating, nineteen have assigned a buy rating and three have assigned a strong buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of "Buy" and an average price target of $603.05.

Get Our Latest Analysis on UnitedHealth Group

UnitedHealth Group Stock Performance

NYSE UNH traded down $6.05 on Tuesday, reaching $418.20. The stock had a trading volume of 9,255,934 shares, compared to its average volume of 4,475,126. The business's 50-day moving average price is $503.28 and its 200 day moving average price is $535.01. The stock has a market cap of $382.53 billion, a P/E ratio of 26.98, a price-to-earnings-growth ratio of 1.37 and a beta of 0.61. UnitedHealth Group has a 12-month low of $412.02 and a 12-month high of $630.73. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing the consensus estimate of $7.29 by ($0.09). The business had revenue of $109.58 billion for the quarter, compared to analyst estimates of $111.56 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. During the same quarter last year, the company posted $6.91 EPS. As a group, equities analysts expect that UnitedHealth Group will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were paid a $2.10 dividend. The ex-dividend date of this dividend was Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 2.01%. UnitedHealth Group's dividend payout ratio (DPR) is presently 35.18%.

Institutional Trading of UnitedHealth Group

Institutional investors and hedge funds have recently bought and sold shares of the company. West Bancorporation Inc. lifted its stake in UnitedHealth Group by 12.4% during the first quarter. West Bancorporation Inc. now owns 763 shares of the healthcare conglomerate's stock worth $400,000 after purchasing an additional 84 shares during the last quarter. Alta Advisers Ltd boosted its holdings in shares of UnitedHealth Group by 49.1% in the 1st quarter. Alta Advisers Ltd now owns 4,557 shares of the healthcare conglomerate's stock valued at $2,387,000 after buying an additional 1,500 shares during the period. Deseret Mutual Benefit Administrators lifted its holdings in UnitedHealth Group by 5.2% in the first quarter. Deseret Mutual Benefit Administrators now owns 1,083 shares of the healthcare conglomerate's stock worth $567,000 after acquiring an additional 54 shares during the last quarter. Smallwood Wealth Investment Management LLC acquired a new stake in UnitedHealth Group in the first quarter worth $107,000. Finally, Saxon Interests Inc. increased its holdings in shares of UnitedHealth Group by 3.8% in the 1st quarter. Saxon Interests Inc. now owns 3,566 shares of the healthcare conglomerate's stock worth $1,868,000 after acquiring an additional 129 shares during the period. Institutional investors and hedge funds own 87.86% of the company's stock.

About UnitedHealth Group

(Get Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Read More

Analyst Recommendations for UnitedHealth Group (NYSE:UNH)

Should You Invest $1,000 in UnitedHealth Group Right Now?

Before you consider UnitedHealth Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.

While UnitedHealth Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

5 Stocks to BUY NOW in May 2025
3 Stocks Offering Rare Generational Buying Opportunities
Make Your Money Work Harder: The Power of Dividend Investing

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines